Imperial College London

Imperial College London is a core academic partner of the COG-UK consortium. Imperial is leading the G2P-UK National Virology Consortium which is studying how SARS-CoV-2 mutations affect how transmissible the virus is, the severity of COVID-19 it causes, and the effectiveness of vaccines and treatments. The team will work alongside COG-UK and Public Health England to boost the UK’s capacity to study newly identified virus variants and rapidly inform government policy.